Stay updated on Psilocybin for Depression in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Depression in Early Alzheimer's Clinical Trial page.

Latest updates to the Psilocybin for Depression in Early Alzheimer's Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site footer now shows revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check12 days agoChange DetectedA banner announces NIH website transition updates and says some NIH content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check19 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now displays a 403 Forbidden error page with the standard ClinicalTrials.gov header and footer, including a Home button to navigate away from the error. This reflects restricted access to the study record rather than a content update.SummaryDifference0.5%

- Check47 days agoChange DetectedThe Study Record page now renders a 403 Forbidden error instead of the study content for the NCT04123314 entry. The previous study details, contacts, and location information have been removed, and a standard 403 page with site navigation is shown.SummaryDifference18%

Stay in the know with updates to Psilocybin for Depression in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Depression in Early Alzheimer's Clinical Trial page.